109 related articles for article (PubMed ID: 3299507)
21. The anti-CCK effect of glutaramic acid derivatives in anesthetized and conscious rats.
Takács T; Nagy I; Pap A; Varró V
Pancreas; 1988; 3(4):465-70. PubMed ID: 3174609
[TBL] [Abstract][Full Text] [Related]
22. Effects of three different cholecystokinin receptor antagonists on basal and stimulated insulin and glucagon secretion in mice.
Karlsson S; Ahrén B
Acta Physiol Scand; 1989 Mar; 135(3):271-8. PubMed ID: 2648765
[TBL] [Abstract][Full Text] [Related]
23. Effects of proglumide on ductal and basolateral secretion of pancreatic digestive enzymes.
Niederau C; Grendell JH; Rothman SS
Am J Physiol; 1985 Jul; 249(1 Pt 1):G100-7. PubMed ID: 2409815
[TBL] [Abstract][Full Text] [Related]
24. Effects of loxiglumide on pancreatic exocrine secretion stimulated by meal in conscious dogs.
Ninomiya K; Saito T; Wakatsuki K; Saeki M; Kato T; Edano K; Kasai H; Kimura K; Fujii M
Arzneimittelforschung; 1998 Jan; 48(1):55-7. PubMed ID: 9522033
[TBL] [Abstract][Full Text] [Related]
25. Discrepancies between the doses of cholecystokinin or caerulein-stimulating exocrine and endocrine responses in perfused isolated rat pancreas.
Otsuki M; Sakamoto C; Yuu H; Maeda M; Morita S; Ohki A; Kobayashi N; Terashi K; Okano K; Baba S
J Clin Invest; 1979 Mar; 63(3):478-84. PubMed ID: 372241
[TBL] [Abstract][Full Text] [Related]
26. Effect of proglumide on rat pancreatic growth.
Yamaguchi T; Tabata K; Johnson LR
Am J Physiol; 1985 Aug; 249(2 Pt 1):G294-8. PubMed ID: 2411150
[TBL] [Abstract][Full Text] [Related]
27. Role of cholecystokinin in pancreatic exocrine response to intraluminal amino acids and fat.
Stubbs RS; Stabile BE
Am J Physiol; 1985 Mar; 248(3 Pt 1):G347-52. PubMed ID: 2858160
[TBL] [Abstract][Full Text] [Related]
28. Role of cholecystokinin in canine pancreatic exocrine response to bombesin stimulation.
Nealon WH; Beauchamp RD; Townsend CM; Thompson JC
Am J Surg; 1987 Jan; 153(1):96-101. PubMed ID: 3799899
[TBL] [Abstract][Full Text] [Related]
29. Physiological control of cholecystokinin release and pancreatic enzyme secretion by intraduodenal bile acids.
Koop I; Schindler M; Bosshammer A; Scheibner J; Stange E; Koop H
Gut; 1996 Nov; 39(5):661-7. PubMed ID: 9026479
[TBL] [Abstract][Full Text] [Related]
30. Diurnal profile of pancreatic exocrine secretion and plasma levels of gut hormones (cholecystokinin and pancreatic polypeptide).
Nakano I; Funakoshi A; Shinozaki H; Miyazaki K; Tateishi K; Hamaoka T
Gastroenterol Jpn; 1987 Dec; 22(6):748-55. PubMed ID: 3443256
[TBL] [Abstract][Full Text] [Related]
31. Selective inhibition of pentagastrin- and cholecystokinin-stimulated exocrine secretion by proglumide.
Loewe CJ; Grider JR; Gardiner J; Vlahcevic ZR
Gastroenterology; 1985 Oct; 89(4):746-51. PubMed ID: 2863192
[TBL] [Abstract][Full Text] [Related]
32. Effects of C-terminal fragments of cholecystokinin on exocrine and endocrine secretion from isolated perfused rat pancreas.
Okabayashi Y; Otsuki M; Ohki A; Sakamoto C; Baba S
Endocrinology; 1983 Dec; 113(6):2210-15. PubMed ID: 6196184
[TBL] [Abstract][Full Text] [Related]
33. Effects of somatostatin and pancreatic polypeptide on exocrine and endocrine pancreas in the rats.
Lee W; Miyazaki K; Funakoshi A
Gastroenterol Jpn; 1988 Feb; 23(1):49-55. PubMed ID: 2895031
[TBL] [Abstract][Full Text] [Related]
34. Pancreatic growth: interaction of exogenous cholecystokinin, a protease inhibitor, and a cholecystokinin receptor antagonist in mice.
Niederau C; Liddle RA; Williams JA; Grendell JH
Gut; 1987; 28 Suppl(Suppl):63-9. PubMed ID: 2446964
[TBL] [Abstract][Full Text] [Related]
35. Effect of a new potent CCK antagonist, lorglumide, on caerulein- and bombesin-induced pancreatic secretion and growth in the rat.
Scarpignato C; Varga G; Dobronyi I; Papp M
Br J Pharmacol; 1989 Mar; 96(3):661-9. PubMed ID: 2470456
[TBL] [Abstract][Full Text] [Related]
36. Role of cholecystokinin in the regulation of gastric emptying and pancreatic enzyme secretion in humans. Studies with the cholecystokinin-receptor antagonist loxiglumide.
Fried M; Erlacher U; Schwizer W; Löchner C; Koerfer J; Beglinger C; Jansen JB; Lamers CB; Harder F; Bischof-Delaloye A
Gastroenterology; 1991 Aug; 101(2):503-11. PubMed ID: 2065926
[TBL] [Abstract][Full Text] [Related]
37. Mechanism of pancreatic growth induced by pancreatico-biliary diversion in the rat. Inhibition by proglumide, benzotript, and ranitidine.
Miazza BM; Turberg Y; Guillaume P; Hahne W; Chayvialle JA; Loizeau E
Scand J Gastroenterol Suppl; 1985; 112():75-83. PubMed ID: 2409583
[TBL] [Abstract][Full Text] [Related]
38. Mechanism of actions of cholecystokinin octapeptide on food intake and insulin and pancreatic polypeptide release in the dog.
Inui A; Okita M; Inoue T; Sakatani N; Oya M; Morioka H; Ogawa T; Mizuno N; Baba S
Peptides; 1988; 9(5):1093-100. PubMed ID: 3072534
[TBL] [Abstract][Full Text] [Related]
39. Role of CCK in regulation of pancreaticobiliary functions and GI motility in humans: effects of loxiglumide.
Schmidt WE; Creutzfeldt W; Schleser A; Choudhury AR; Nustede R; Höcker M; Nitsche R; Sostmann H; Rovati LC; Fölsch UR
Am J Physiol; 1991 Feb; 260(2 Pt 1):G197-206. PubMed ID: 1996640
[TBL] [Abstract][Full Text] [Related]
40. Characterization of a new CCK antagonist, L364,718: in vitro and in vivo studies.
Louie DS; Liang JP; Owyang C
Am J Physiol; 1988 Sep; 255(3 Pt 1):G261-6. PubMed ID: 2458681
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]